AN2 THERAPEUTICS INC's ticker is and the CUSIP is 037326105. A total of 52 filers reported holding AN2 THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $92 | -89.9% | 28,318 | -36.0% | 0.00% | – |
| Q4 2023 | $907 | +1678.4% | 44,238 | +1295.5% | 0.00% | – |
| Q3 2023 | $51 | -77.8% | 3,170 | -88.3% | 0.00% | – |
| Q2 2023 | $230 | -28.8% | 27,074 | -17.4% | 0.00% | – |
| Q1 2023 | $323 | +12.9% | 32,773 | +9.0% | 0.00% | – |
| Q4 2022 | $286 | -99.9% | 30,058 | +10.2% | 0.00% | -100.0% |
| Q3 2022 | $475,000 | +1150.0% | 27,278 | +458.1% | 0.00% | – |
| Q2 2022 | $38,000 | -86.2% | 4,888 | -73.2% | 0.00% | – |
| Q1 2022 | $275,000 | – | 18,220 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 1,289,320 | $10,959,220 | 1.80% |
| Octagon Capital Advisors LP | 720,900 | $6,127,650 | 0.85% |
| RA Capital Management | 3,773,517 | $32,074,895 | 0.61% |
| BVF INC/IL | 1,563,963 | $13,293,686 | 0.37% |
| Monashee Investment Management LLC | 181,995 | $1,546,958 | 0.37% |
| Avidity Partners Management LP | 657,200 | $5,586,200 | 0.20% |
| Y-Intercept (Hong Kong) Ltd | 14,040 | $119,340 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 27,500 | $233,750 | 0.01% |
| Alyeska Investment Group, L.P. | 98,426 | $836,621 | 0.01% |
| JANUS HENDERSON GROUP PLC | 1,000,068 | $8,590,578 | 0.01% |